In Vitro Chronic Administration of ERbeta Selective Ligands and Prostate Cancer Cell Growth: Hypotheses on the Selective Role of 3beta-Adiol in AR-Positive RV1 Cells
Figure 7
Transcriptional activity of ERbeta agonists in Rv1 (a) and in HEK 293 (b) cells: data are expressed as mean ± SD of the ratio between the luminescence (RLU) of the experimental over the control reporter; versus C and 3beta-Adiol 1 and 10 nM; versus C and 3beta-Adiol 1 and 10 nM; versus C and 8beta-VE2 1 and 10 nM; versus 8beta-VE2 1 nM.